Innovex International (INVX) Cash & Equivalents (2009 - 2026)

Innovex International's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $200.7 million for Q1 2026.

• Quarterly Cash & Equivalents rose 194.65% year-over-year to $200.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.7 million (up 194.65% YoY) and the FY2025 annual result came in at $203.4 million, up 177.58% from the prior year.
• Cash & Equivalents was $200.7 million for Q1 2026 at Innovex International, down from $203.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $338.0 million in Q1 2022 and bottomed at $7.4 million in Q4 2023.
• A 5-year average of $137.7 million and a median of $99.9 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 97.14% — and 2024, when it surged 1102.54%.
• Innovex International's Cash & Equivalents stood at $8.4 million in 2022, then declined by 12.0% to $7.4 million in 2023, then jumped by 889.44% to $73.3 million in 2024, then surged by 177.58% to $203.4 million in 2025, then fell by 1.33% to $200.7 million in 2026.
• Business Quant data shows INVX's Cash & Equivalents at $200.7 million in Q1 2026, $203.4 million in Q4 2025, and $163.4 million in Q3 2025.